Dr. David Schiff, MD
Claim this profileUniversity of Virginia Cancer Center
Studies Glioblastoma
Studies Neurofibromatosis
7 reported clinical trials
20 drugs studied
Area of expertise
1Glioblastoma
IDH negative
MET positive
MGMT negative
2Neurofibromatosis
SMO positive
PTCH1 positive
NF1 positive
Affiliated Hospitals
Clinical Trials David Schiff, MD is currently running
Multiple Therapies
for Glioblastoma
This trial is testing various treatments for patients with newly diagnosed or returning brain cancer. It adjusts treatments based on how well patients are doing to find the most effective options. The goal is to improve survival rates by matching the best treatments to specific patient types.
Recruiting1 award Phase 2 & 310 criteria
Selinexor + Temozolomide
for Recurrent Glioblastoma
This trial tests selinexor with temozolomide for patients whose brain cancer has returned. Selinexor blocks a protein that helps cancer cells grow, and temozolomide damages their DNA to kill them or stop their growth. Temozolomide is a DNA methylating drug currently used as a first-line treatment in glioblastoma therapy.
Recruiting1 award Phase 1 & 2
More about David Schiff, MD
Clinical Trial Related5 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments David Schiff, MD has experience with
- Temozolomide
- Mirdametinib (PD-0325901)
- VAL-083
- VT1021
- Lomustine
- Troriluzole
Breakdown of trials David Schiff, MD has run
Glioblastoma
Meningioma
Recurrence
Neurofibroma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does David Schiff, MD specialize in?
David Schiff, MD focuses on Glioblastoma and Neurofibromatosis. In particular, much of their work with Glioblastoma has involved IDH negative patients, or patients who are MET positive.
Is David Schiff, MD currently recruiting for clinical trials?
Yes, David Schiff, MD is currently recruiting for 5 clinical trials in Charlottesville Virginia. If you're interested in participating, you should apply.
Are there any treatments that David Schiff, MD has studied deeply?
Yes, David Schiff, MD has studied treatments such as Temozolomide, Mirdametinib (PD-0325901), VAL-083.
What is the best way to schedule an appointment with David Schiff, MD?
Apply for one of the trials that David Schiff, MD is conducting.
What is the office address of David Schiff, MD?
The office of David Schiff, MD is located at: University of Virginia Cancer Center, Charlottesville, Virginia 22908 United States. This is the address for their practice at the University of Virginia Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.